Infondrian's ChartAlert Launches at Mount Sinai

August 10, 2020 – Infondrian released the next generation cloud-native treatment monitoring platform, ChartAlert Cloud, for beta testing at the Mount Sinai Health System (New York, NY). For the first time, care teams in radiation oncology can monitor the cancer treatment in near real-time. The cloud platform enables processing thousands of treatment records efficiently.

Infondrian Receives NIH STTR Phase II Grant

Sept. 10, 2019 – Infondrian LLC is pleased to announce receiving a Small Business Technology Transfer Phase II award from Department of Health and Human Services, National Institutes of Health. This two-year $1.7M grant will enable us to continue developing and clinically validating the next-generation automated treatment error detection software to improve patient safety, prevent treatment errors, reduce healthcare cost, and increase chart checking efficiency in radiation therapy.

Infondrian Launches ChartAlert V1.5

May 25, 2018 – After 17 months of development and clinical validation, Infondrian today releases revolutionary ChartAlert V1.50 software for beta testing. University of Iowa Hospitals and Clinics and Great River Medical Systems are among the first institutions to receive this update. ChartAlert software automatically checks approximately 120 patient treatments on daily basis, significantly improving the efficiency of detecting treatment errors.